会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Cell sodding method and apparatus
    • 细胞浸渍法和装置
    • US08202725B2
    • 2012-06-19
    • US11314281
    • 2005-12-22
    • Paul E. KosnikChristopher T. EnglandRobert G. DennisStuart K. Williams
    • Paul E. KosnikChristopher T. EnglandRobert G. DennisStuart K. Williams
    • C12N5/00
    • C12N5/0697C12M21/08C12M25/10C12M25/14C12M27/10C12M29/10C12N2533/30
    • Tissue engineering methods and biochamber apparatus are provided for making tissue grafts for implantation into a patient. The methods include applying a sustained low magnitude pressure gradient transmurally across a permeable scaffold material using a media containing cells, preferably microvascular epithelial cells, to be deposited on the scaffold for the production of tissue grafts, preferably vascular grafts, to promote accelerated adhesion and maturation of cells on the scaffold material. Biochambers for preparing tubular tissue grafts are provided which contain connectors for holding a graft substrate, proximal and distal tubing for connection to an optional perfusion system, and structure for switching between transmural flow of a cell suspension across the graft substrate and translumenal flow through the lumen of the graft.
    • 提供组织工程方法和生物处理设备用于制造植入患者体内的组织移植物。 所述方法包括使用包含细胞(优选微血管上皮细胞)的培养基透过可渗透的支架材料跨度施加持续的低幅度压力梯度,以沉积在支架上用于生产组织移植物,优选血管移植物,以促进加速粘附和成熟 的细胞在脚手架材料上。 提供了用于制备管状组织移植物的生物体,其包含用于保持移植物基质的连接器,用于连接到任选的灌注系统的近端和远端管,以及用于在穿过移植物基质的细胞悬浮液的跨壁流和通过内腔的经血流之间切换的结构 的移植物。
    • 2. 发明申请
    • CATHETER FOR CELL DELIVERY
    • 电池输送管
    • US20090192454A1
    • 2009-07-30
    • US12418551
    • 2009-04-03
    • Eugene BolandStuart K. WilliamsPaul E. Kosnik
    • Eugene BolandStuart K. WilliamsPaul E. Kosnik
    • A61M25/10A61M25/00A61M5/178
    • A61M25/10182A61M25/007A61M25/10184A61M2025/0057A61M2025/105A61M2025/1075
    • A cell delivery system and method for delivering cells locally to a tissue, body cavity, or joint is described. The cell delivery system comprises a catheter configured to deliver stem cells in a pressure controlled manner. The catheter may comprise an inner bladder and an outer perforated bladder. The inner bladder may be expanded through the use of a pressure conduit in order to deploy a stent. Cells, such as endothelial cells derived from adipose tissue, may be introduced between the inner and outer bladder. The inner bladder may be further expanded in order to exert pressure on the outer perforated bladder to advance the stems cells though the apertures of the outer bladder. The inner bladder may remain pressurized to hold the outer bladder against the vessel wall, thereby directing the stem cells to specific target sites. The system may be used to deliver stem cells with or without other therapeutic agents. The system may be used with or without a stent. The system may further comprise a pressure gauge that permits measurement and regulation of pressure within the catheter.
    • 描述了将细胞局部递送至组织,体腔或关节的细胞递送系统和方法。 细胞递送系统包括配置成以压力控制的方式递送干细胞的导管。 导管可以包括内囊和外穿孔囊。 可以通过使用压力导管来扩张内囊,以便展开支架。 可以在内囊和外囊之间引入细胞,例如源自脂肪组织的内皮细胞。 内囊可以进一步膨胀以便在外部穿孔的膀胱上施加压力,以通过外囊的孔推进杆细胞。 内囊可以保持加压以将外囊保持抵靠血管壁,从而将干细胞引导到特定的靶位点。 该系统可用于递送具有或不具有其它治疗剂的干细胞。 该系统可以在有或没有支架的情况下使用。 该系统还可以包括允许测量和调节导管内的压力的压力计。
    • 3. 发明申请
    • Cell delivery matrices
    • 细胞递送矩阵
    • US20080160085A1
    • 2008-07-03
    • US11901138
    • 2007-09-13
    • Eugene D. BolandStuart K. WilliamsPaul E. Kosnik
    • Eugene D. BolandStuart K. WilliamsPaul E. Kosnik
    • A61K9/00A61K35/12
    • A61K9/4808A61K9/0019A61K35/36A61K35/44A61K47/42A61L27/16A61L27/18A61L27/225A61L27/24A61M25/104C12N5/0653C08L27/18C08L67/02
    • Cell delivery matrices and methods for facilitating local delivery of adipose derived endothelial cells to a target tissue, body cavity, or joint are described. The cell delivery matrix may be a three-dimensional matrix scaffold comprising fibrin derived from the patient's own body. The cell delivery matrix may be biocompatible and semi-permeable. The cell delivery matrix used in the methods of the invention may be comprised of any degradable, bioabsorbable or non-degradable, biocompatible polymer. Regenerative therapies comprising implanting in the subject cell delivery matrices localizing adipose derived endothelial cells are described. The cell delivery matrices maintain the adipose derived endothelial cells at the target for a therapeutically effective amount of time. The adipose derived endothelial cells can be allogenic or syngenic to the subject. The endothelial cells may be delivered alone or in combination with other therapeutic agents.
    • 描述了用于促进将脂肪来源的内皮细胞局部递送至靶组织,体腔或关节的细胞递送基质和方法。 细胞递送基质可以是包含衍生自患者本身的纤维蛋白的三维基质支架。 细胞递送基质可以是生物相容性的和半渗透性的。 用于本发明方法的细胞递送基质可以由任何可降解的,生物可吸收的或不可降解的生物相容性聚合物组成。 描述了包含植入本发明的细胞递送基质定位脂肪来源的内皮细胞的再生疗法。 细胞递送基质将靶向脂肪来源的内皮细胞维持在治疗有效的时间量。 脂肪来源的内皮细胞可以是同种异体的或与受试者同源的。 内皮细胞可以单独递送或与其它治疗剂组合递送。